# Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus

> **NCT05779644** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Metformin
- Obesity, Abdominal
- Diabetes Mellitus, Type 2
- Abdominal Fat
- Non-Alcoholic Fatty Liver Disease
- Metabolism Disorder, Glucose
- Metabolism Disorder, Lipid

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Semaglutide
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05779644
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-23
- **Primary completion:** 2025-02-23
- **Final completion:** 2025-02-23
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05779644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05779644, "Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05779644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*